Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 389.84K | $ 464.10K | $ 1.07M | $ 1.67M | $ 216.41K |
Total Assets | $ 4.78M | $ 4.98M | $ 5.42M | $ 6.01M | $ 4.60M |
Total Debt | $ ― | $ ― | $ ― | $ 0.00 | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ -1.67M | $ ― |
Total Liabilities | $ 187.56K | $ 237.86K | $ 164.88K | $ 324.62K | $ 294.17K |
Stockholders Equity | $ 4.59M | $ 4.74M | $ 5.25M | $ 5.69M | $ 4.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |